SEC Form 4 · accession 0001640455-18-000072
Jounce Therapeutics, Inc. · JNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hugh M Cole
Officer — Chief Business Officer
Period of report
Jun 15, 2018
Accepted (ET)
Jun 18, 2018 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001640455
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2018 | P | 1,900 | $7.84 | A | 1,900 | D |
Table II — derivative securities
No Table II lines on this filing.